Actavis Recalls Nifedipine Capsules Due to Presence of Foreign Tablets
Actavis Elizabeth LLC is recalling Nifedipine Capsules USP, 10 mg, because the product may contain foreign tablets or capsules.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The hazard involves the presence of foreign tablets or capsules, which is a quality control issue rather than a high-risk pathogen or structural defect.
Plain-English summary
Actavis Elizabeth LLC is voluntarily recalling Nifedipine Capsules USP, 10 mg, Rx only, 100 count bottles. The recall is being conducted because the product may contain foreign tablets or capsules.
The affected product is identified by NDC 0228-2407-10, Lot # 0598B151, and an expiration date of 03/18. A total of 27,517 bottles were distributed in the United States.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- NIFEdipine Capsules USP, 10 mg, Rx only, 100 count bottle, Manufactured and distributed by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-2407-10
- Manufacturer
- Actavis Elizabeth LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 27,517
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 0598B151
- Exp 03/18
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · Actavis Elizabeth LLC
See all →- SevereActavis Recalls Dextroamphetamine Tablets Due to Impurity Failures
FDA (Drugs) · 2016-04-13
- ModerateActavis Recalls Dextroamphetamine Tablets Due to Impurity Failures
FDA (Drugs) · 2016-04-13
- ModerateActavis Recalls Dextroamphetamine Tablets for Impurity Failures
FDA (Drugs) · 2016-04-13
- SevereActavis Recalls Amphetamine Tablets Due to Impurity Failures
FDA (Drugs) · 2016-04-13
- ModerateActavis Recalls Dextroamphetamine Sulfate Capsules for Dissolution Failures
FDA (Drugs) · 2015-03-11
Same hazard · foreign object
See all →- ModerateMezzetta Golden Greek Peperoncini Recalled for Potential Mouse Contamination
FDA (Food) · 2026-10-14
- SevereUnited and Good & Gather Light Brown Sugar Recalled for Wheat Contamination
FDA (Food) · 2026-09-30
- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
- ModerateBionpharma Recalls Doxylamine Succinate Tablets Due to Foreign Material Presence
FDA (Drugs) · 2026-09-09
- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateAHP Nifedipine Capsules Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2016-11-30
- ModerateActavis Recalls Alprazolam Extended-Release Tablets for Dissolution Failures
FDA (Drugs) · 2014-03-12
- SevereActavis Recalls Amphetamine Tablets Due to Impurity Failures
FDA (Drugs) · 2016-04-13
- ModerateActavis Recalls Dextroamphetamine Tablets Due to Impurity Failures
FDA (Drugs) · 2016-04-13
- ModerateActavis Recalls Dextroamphetamine Tablets for Impurity Failures
FDA (Drugs) · 2016-04-13
- HighAuroMedics Recalls Gabapentin Capsules Due to Foreign Tablet Presence
FDA (Drugs) · 2019-12-25